An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of COVID-19, a study suggests.
US researchers reported a 91% survival rate in seriously ill patients given the stem cell infusion, compared to 42% in a second group who did not receive the treatment.
Researchers said the treatment also appeared to be safe, with no serious adverse reactions reported.
Source: The Independent, 5 January 2021
Recommended Comments
Create an account or sign in to comment